In our present IHC study of NAFLD patients, we detected significantly higher RIG1, IRF3, pNRF2, and SOCS3 protein expressions in NASH patients compared with NAFL patients. Here, SOCS3 is linked to metabolic dysfunction-associated steatohepatitis.